Dr Randolph Seidler | Managing Director, Veterinary Research Centre & VP, Global Head of BD
Boehringer Ingelheim Animal Health Gmbh

Dr Randolph Seidler, Managing Director, Veterinary Research Centre & VP, Global Head of BD, Boehringer Ingelheim Animal Health Gmbh

Dr. Randolph Seidler received his training in veterinary medicine from the Ludwig-Maximilians University (LMU) in Munich, Germany. He did his Ph.D. research at The Ohio State University in Columbus, Ohio, and the LMU in the area of cardiac physiology and pharmacology. He joined Boehringer Ingelheim's human pharma R&D conducting research in the area of general pharmacology and cardiovascular drug discovery in Biberach, Germany and in Ridgefield, Connecticut. During this time, Dr. Seidler headed a group of scientists in the area of heart failure and myocardial infarction research and led several drug discovery projects that progressed to clinical development. In July 2007, he was appointed head of Global Department R&D at Boehringer Ingelheim's Animal Health business, overseeing global Research and Development of pharmaceuticals and vaccines, Regulatory Affairs, Pharmacovigilance and Quality Assurance. The R&D group at Boehringer Ingelheim’s Animal Health currently consists of approximately 550 employees located in Germany, the US, China, Mexico and Japan


Day 2 Oct 11th Veterinary @ 14:40

Manufacturing within the veterinary industry – the future of where it’s going

  • The significance of manufacturing quality control for veterinary vaccine development and vaccine efficacy
  •  New manufacturing technologies to that could potentially be commercially viable, and enable effective and rapid response during outbreaks 
  • Challenges the veterinary vaccine manufacturing is currently facing and steps to overcome these

back to speakers